Tina Cascone

Oncology

210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Navigating Multimodality Therapy in Non-Small Cell Lung Cancer: Neoadjuvant-Only Versus Perioperative Immunotherapy, Surgical Imperatives, and Future Approaches.

Navigating Multimodality Therapy in Non-Small Cell Lung Cancer: Neoadjuvant-Only Versus Perioperative Immunotherapy, Surgical Imperatives, and Future Approaches.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: July 15, 2026

The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.

The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.

Journal: Nature cancer

Published: June 18, 2026

Unbiased avidity-based isolation of antigen-specific T cells.

Unbiased avidity-based isolation of antigen-specific T cells.

Journal: Journal for immunotherapy of cancer

Published: June 11, 2026

Unbiased avidity-based isolation of antigen-specific T cells.

Unbiased avidity-based isolation of antigen-specific T cells.

Journal: Journal for immunotherapy of cancer

Published: June 11, 2026

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer.

Journal: Nature reviews. Clinical oncology

Published: June 05, 2026

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center.

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center.

Journal: Clinical lung cancer

Published: June 05, 2026

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 26, 2026

Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.

Neoadjuvant and perioperative chemo-immunotherapy in early-stage non-small cell lung cancer: international expert panel meeting by AIOT.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 23, 2026

Ivonescimab in advanced squamous non-small-cell lung cancer: can we raise the survival bar?

Ivonescimab in advanced squamous non-small-cell lung cancer: can we raise the survival bar?

Journal: Lancet (London, England)

Published: May 19, 2026

Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.

Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges.

Journal: The Lancet. Respiratory medicine

Published: May 09, 2026

CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer.

CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer.

Journal: medRxiv : the preprint server for health sciences

Published: May 04, 2026

Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

Journal: JCO precision oncology

Published: April 23, 2026

Showing 1-12 of 144

Last Updated: 09/26/2026